K2 HealthVentures provides growth capital, venture debt, and other structured financing solutions to commercial-stage and late-stage healthcare companies. Their focus spans biopharmaceuticals, medical devices, diagnostics, and digital health, offering non-dilutive or minimally dilutive capital.
86% of their portfolio is in Healthcare. Average disclosed round size is $120.5M (across 7 rounds with reported amounts).
Portfolio
7
Fund Size
$200M
Top Stage
Series B
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Honest Health | Growth | $140M | Feb 2026 |
 Zarminali Pediatrics | Series A | $110M | Jan 2026 |
 Apella | Series B | $80M | Jan 2026 |
 Umoja Biopharma | Series C | $100M | Jan 2025 |
 Evergreen Nephrology | Series D | $130M | Jan 2025 |
 HarmonyCares | Series D | $200M | Jul 2024 |
 Cricket Health | Series B | $83.5M | Aug 2021 |
Top Co-Investors
Oak HC/FT4 shared
General Catalyst2 shared
Rubicon Founders2 shared
Valtruis2 shared
Casdin Capital1 shared
Operator Partners1 shared
HighlandX1 shared
McKesson Ventures1 shared
HLM Venture Partners1 shared
Double Point Ventures1 shared
DCVC1 shared
ARK Invest1 shared
Cormorant Asset Management1 shared
MPM Capital1 shared
Qiming Venture Partners USA1 shared
RTW Investments1 shared
Alexandria Venture Investments1 shared
SoftBank Vision Fund1 shared
CaaS Capital1 shared
Durable Capital Partners1 shared
Last updated: 16 April 2026